Device Trial Radar · NCT06615739
Comprehensive SRS Regenerex Tissue Attachment
Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
22
Actual
Start
Oct 22, 2024
Primary completion
Feb 26, 2026
Study completion Feb 26, 2026
Sponsor
- Lead sponsor
- Zimmer BiometPublic (ZBH)
- Sponsor type
- Industry
- First posted
- Sep 27, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.
Conditions
- Arthroplasty Complications
- Osteo Arthritis Shoulders
Interventions
Regenerex Tissue Attachment AugmentsDevice
Patient will have been previously implanted with Regenerex Tissue Attachment Augments in combination with the Comprehensive Segmental Revision System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Kaplan Meier Implant SurvivorshipTime frame: Up to 10 Years
- Safety AssessementTime frame: Up to 10 Years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Toman Orthopedics and Sports Med
Boca Raton, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.